The Supreme Court has asked the Biden administration to comment on the RoundUp weed killer case before it. Bayer execs see this as an indication that the court is taking an interest in it, and appear hopeful that the glyphosate litigation can finally be put to rest without adding to the already staggering cost to the company. The 2018 acquisition of Monsanto,...
BAYER is one of those companyes that are under valued right now. The book value per share turns out to be 47.52 per share. This is another insanely cheep stock or simply a bargain. Especially seeing it is a Biotech and it is located in Germany, EU. So it is kind of not as impacted by the civil unrest in the United States of North America. I have been long on...
President Donald Trump and the Food and Drug Administration commissioner appeared to exchange conflicting statements about how a decades-old antimalaria drug is being used to treat COVID-19. The drug in question is chloroquine. It is sold under the brand name Aralen and in generic form. It is also available in a different formulation as hydroxychloroquine under...
BAYRY is approaching a resistance where a corresponding reversal could occur.
After break of low around 17 BAYRY retraced to breakout down - broke the 17 low into new low territory - has retraced to breakout Note: with all the litigation, the potential damages claims, BAYRY has such a big question around it, it would appear there is only one direction it can move, how big is is anyone's guess? maybe the lawyers can tell us....
BAYRY is approaching our first support where we might see a corresponding bounce in price to our major resistance at 19.71. Stochastic is also approaching support where we might see a corresponding bounce in price.
BAYRY is approaching support where a potential bounce to its resistance could occur.